Favourable outcome for allogeneic haematopoietic transplant recipients requiring intensive therapy unit admission with improved survival following reduced intensity conditioning

被引:0
|
作者
Holroyd, A. [1 ]
Townsend, W. [1 ]
Naik, P. [2 ]
Mackinnon, S. [3 ]
Howell, D. [2 ]
Goldstone, A. [1 ]
Linch, D. [3 ]
Peggs, K. [3 ]
Thomson, K. [1 ]
Singer, M. [2 ]
Morris, E. [3 ]
机构
[1] Univ Coll London Hosp NHS Trust, London, England
[2] Barking Havering & Redbridge Hosp NHS Trust, Essex, England
[3] UCL, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
105
引用
收藏
页码:42 / 42
页数:1
相关论文
共 50 条
  • [31] Myeloablative after reduced-intensity conditioning allogeneic stem cell transplant: toxicity and outcome?
    Cordonnier, C
    Hamladji, R
    Genitsch, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S361 - S362
  • [32] A comparative review of children requiring admission to intensive care unit following haemopoietic stem cell transplant
    Weatherby, S.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S333 - S333
  • [33] Incidence and outcome of Adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab
    Avivi, I
    Chakrabarti, S
    Milligan, DW
    Waldmann, H
    Hale, G
    Osman, H
    Ward, KN
    Fegan, CD
    Yong, K
    Goldstone, AH
    Limb, DC
    MacKinnon, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (03) : 186 - 194
  • [34] Outcome After Admission to Intensive Care Unit (ICU) in Hematopoietic Transplant Recipients: Single Centre Experience
    Iturrate, Isabel
    Ruiz, Analys
    Mayor, Carlota
    Puchol, Ana
    Diaz, Sofia
    Figuera, Angela
    Alegre, Adrian
    Aguado, Beatriz
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 158 - 159
  • [35] CHARACTERISTICS AND OUTCOME OF LUNG TRANSPLANT PATIENTS REQUIRING ADMISSION TO MEDICAL INTENSIVE CARE UNIT: ONE YEAR STUDY
    Banga, Amit
    Sahoo, Debasis
    Budev, Marie
    Sasidhar, Madhu
    CRITICAL CARE MEDICINE, 2012, 40 (12) : U29 - U30
  • [36] Higher Doses of CD34+Progenitors are Associated with Improved Overall Survival Without Increasing GVHD in Reduced Intensity Conditioning Allogeneic Transplant Recipients With Clinically Advanced Disease
    Gomez-Almaguer, David
    Gomez-Pena, Alvaro
    Carlos Jaime-Perez, Jose
    Angel Gomez-Guijosa, Miguel
    Cantu-Rodriguez, Olga
    Gutierrez-Aguirre, Homero
    Aide Martinez-Cabriales, Sylvia
    Garcia-Rodriguez, Fernando
    Olguin-Ramirez, Leticia A.
    Salazar-Riojas, Rosario
    Mendez-Ramirez, Nereida
    JOURNAL OF CLINICAL APHERESIS, 2013, 28 (05) : 349 - 355
  • [37] Impact of chimerism and other transplant variables on allogeneic transplant outcome after reduced intensity conditioning (RIC) regimens.
    Corbella, Veronica Ortiz
    Le, Quoc-Hung
    Nicolini, Franck E.
    Thiebaut, Anne
    Thomas, Xavier
    Chelgoum, Youcef
    Ducastelle, Sophie
    Mollet, Isabelle
    Dubois, Valerie
    Michallet, Mauricette
    BLOOD, 2006, 108 (11) : 406B - 406B
  • [38] Survival and prognostic factors of allogeneic hematopoietic stem cell transplant recipients admitted to intensive care unit
    Moreau, Anne-Sophie
    Seguin, Amelie
    Lemiale, Virginie
    Yakoub-Agha, Ibrahim
    Girardie, Patrick
    Robriquet, Laurent
    Mangalaboyi, Jacques
    Fourrier, Francois
    Jourdain, Merce
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1417 - 1420
  • [39] Impact of donor lymphocyte infusion on outcome after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation
    Michallet, M
    Mohty, M
    Le, QH
    Michallet, AS
    Faucher, C
    Thiebaut, A
    Tavernier, E
    Raffi, H
    Revesz, D
    Troncy, J
    Praire, A
    Gadolet, E
    Raus, N
    Dubois, V
    Gebuhrer, L
    Hequet, O
    Bourgeot, JC
    Nicolini, F
    BONE MARROW TRANSPLANTATION, 2005, 35 : S204 - S205
  • [40] Quality of life following reduced-intensity conditioning haematopoietic stem cell transplant among recipients aged over 50 years: an interpretative phenomenological analysis
    Gilfillan, R.
    Hewitt, C. J.
    Wilson, S. L.
    Mullen, K.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S500 - S500